Article info

Download PDFPDF

Original article
Incidence of inpatient venous thromboembolism in treated patients with rheumatoid arthritis and the association with switching biologic or targeted synthetic disease-modifying antirheumatic drugs (DMARDs) in the real-world setting

Authors

  1. Correspondence to Dr Huifang Liang; huifang.liang{at}abbvie.com
View Full Text

Citation

Liang H, Danwada R, Guo D, et al
Incidence of inpatient venous thromboembolism in treated patients with rheumatoid arthritis and the association with switching biologic or targeted synthetic disease-modifying antirheumatic drugs (DMARDs) in the real-world setting

Publication history

  • Received May 16, 2019
  • Revision received August 30, 2019
  • Accepted September 4, 2019
  • First published September 23, 2019.
Online issue publication 
September 23, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.